Inside informationEnglish
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 13/04/2026, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 115337_20260413